Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma

Glioblastoma multiforme (GBM), a primary brain malignancy characterized by high morbidity, invasiveness, proliferation, relapse and mortality, is resistant to chemo- and radiotherapies and lacks effective treatment. GBM tumors undergo metabolic reprograming and develop anti-apoptotic defenses. We ta...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Shteinfer-Kuzmine, Anna, Arif, Tasleem, Krelin, Yakov, Tripathi, Shambhoo Sharan, Paul, Avijit, Shoshan-Barmatz, Varda
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458211/
https://ncbi.nlm.nih.gov/pubmed/28412744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15455
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia